ZUNVIGO

Serial Number 98009745
732

Registration Progress

Application Filed
May 23, 2023
Under Examination
Dec 19, 2023
Approved for Publication
Oct 24, 2023
Published for Opposition
Oct 24, 2023
Registered

Attorney Assistance

Statement of Use Due - Extension 3 Granted
Due: Dec 19, 2025 139 days

Trademark Image

ZUNVIGO

Basic Information

Serial Number
98009745
Filing Date
May 23, 2023
Published for Opposition
October 24, 2023
Drawing Code
3

Status Summary

Current Status
Active
Status Code
732
Status Date
Jun 4, 2025
Application
Pending
Classes
005

Rights Holder

Dizal (Jiangsu) Pharmaceutical Co., Ltd.

99
Address
Room 404, 405,416, Building C, Huirong
Business Plaza, 26 Hefeng Road, Xinwu
Wuxi, Jiangsu 214028
CN

Ownership History

Dizal (Jiangsu) Pharmaceutical Co., Ltd.

Original Applicant
99
Wuxi, Jiangsu CN

Dizal (Jiangsu) Pharmaceutical Co., Ltd.

Owner at Publication
99
Wuxi, Jiangsu CN

Legal Representation

Attorney
Jinggao LI

USPTO Deadlines

Next Deadline
139 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
December 19, 2025
Extension Available
Until December 19, 2024

Application History

24 events
Date Code Type Description Documents
Jun 4, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jun 4, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 4, 2025 EXT3 S SOU EXTENSION 3 FILED Loading...
May 1, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 1, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 28, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 14, 2025 PETG O PETITION TO REVIVE-GRANTED Loading...
Feb 14, 2025 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION Loading...
Feb 14, 2025 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Feb 14, 2025 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Dec 20, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Jun 18, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 18, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 18, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 18, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 19, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 24, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 24, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 4, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 19, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 14, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 27, 2023 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jun 25, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 26, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Anti-cancer preparations; Biological preparations for the treatment of cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer and tumor; Chemical reagents for medical or veterinary purposes; Chemical reagents for medical purposes; Mixed biological preparations for the prevention and treatment of infectious diseases; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for the treatment of human illnesses, namely, anti-tumor treatment; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, elixirs for the treatment of anti-tumor treatment and cancer; Pharmaceutical products for the prevention and treatment of cancer

Additional Information

Design Mark
The mark consists of the stylized wording "ZUNVIGO" with two double helix designs to the left of the wording.
Color Claim
Color is not claimed as a feature of the mark.
Translation
The wording ZUNVIGO has no meaning in a foreign language.

Classification

International Classes
005